Domain substructure of HPV E6 oncoprotein: biophysical characterization of the E6 C-terminal DNA-binding domain.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Biochemistry

• Publication date

  2003-05-06

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/BI026980CPMID 12718532
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Human Papillomavirus 16 E6 Protein Binds to Tumor Necrosis Factor (TNF) R1 and Protects Cells from TNF-induced Apoptosis*

  2002cited by this paper
• Interference of papillomavirus E6 protein with single‐strand break repair by interaction with XRCC1

  2002cited by this paper
• Human Papillomavirus Oncoprotein E6 Inactivates the Transcriptional Coactivator Human ADA3

  2002cited by this paper
• Interaction of oncogenic papillomavirus E6 proteins with fibulin-1.

  2002cited by this paper
• The DNA repair protein, O6-Methylguanine-DNA methyltransferase is a proteolytic target for the E6 human papillomavirus oncoprotein

  2002cited by this paper
• Effects of temperature on the dynamic behaviour of the HIV-1 nucleocapsid NCp7 and its DNA complex.

  2002cited by this paper
• Formation of soluble inclusion bodies by hpv e6 oncoprotein fused to maltose-binding protein.

  2001cited by this paper
• Contributions in the domain of cancer research: Review¶Human papillomaviruses and their role in cervical cancer

  2001cited by this paper
• Telomerase Activation by Human Papillomavirus Type 16 E6 Protein: Induction of Human Telomerase Reverse Transcriptase Expression through Myc and GC-Rich Sp1 Binding Sites

  2001cited by this paper
• Specific recognition of four-way DNA junctions by the C-terminal zinc-binding domain of HPV oncoprotein E6.

  2001cited by this paper
• Dynamics of the Mrf-2 DNA-binding domain free and in complex with DNA.

  2001cited by this paper
• Protein dynamic studies move to a new time slot

  2001cited by this paper
• Purification and biophysical characterization of a minimal functional domain and of an N-terminal Zn2+-binding fragment from the human papillomavirus type 16 E6 protein.

  2001cited by this paper
• E Box-Dependent Activation of Telomerase by Human Papillomavirus Type 16 E6 Does Not Require Induction of c-myc

  2001cited by this paper
• A strategy for optimizing the monodispersity of fusion proteins: application to purification of recombinant HPV E6 oncoprotein.

  2001cited by this paper
• Transcriptional Activation of the Telomerase hTERT Gene by Human Papillomavirus Type 16 E6 Oncoprotein

  2001cited by this paper
• Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins

  2000cited by this paper
• Human Scribble (Vartul) Is Targeted for Ubiquitin-Mediated Degradation by the High-Risk Papillomavirus E6 Proteins and the E6AP Ubiquitin-Protein Ligase

  2000cited by this paper
• The influence of DNA binding on the backbone dynamics of the yeast cell-cycle protein Mbp1*

  2000cited by this paper
• Multi-PDZ Domain Protein MUPP1 Is a Cellular Target for both Adenovirus E4-ORF1 and High-Risk Papillomavirus Type 18 E6 Oncoproteins

  2000cited by this paper
• PKN Binds and Phosphorylates Human Papillomavirus E6 Oncoprotein*

  2000cited by this paper
• HPV oncoprotein E6 is a structure-dependent DNA-binding protein that recognizes four-way junctions.

  2000cited by this paper
• The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha.

  1999cited by this paper
• The Human Papillomavirus Type 16 E6 Oncoprotein Can Down-Regulate p53 Activity by Targeting the Transcriptional Coactivator CBP/p300

  1999cited by this paper
• The role of the E6-p53 interaction in the molecular pathogenesis of HPV

  1999cited by this paper
• The E6 Oncoproteins of High-Risk Papillomaviruses Bind to a Novel Putative GAP Protein, E6TP1, and Target It for Degradation

  1999cited by this paper
• The E6 protein of human papillomavirus type 16 binds to and inhibits co‐activation by CBP and p300

  1999cited by this paper
• Analyzing protein circular dichroism spectra for accurate secondary structures

  1999cited by this paper
• Human papillomavirus oncoprotein E6 binds to the C-terminal region of human minichromosome maintenance 7 protein.

  1998cited by this paper
• Association of Bovine Papillomavirus Type 1 E6 oncoprotein with the focal adhesion protein paxillin through a conserved protein interaction motif

  1998cited by this paper
• Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway.

  1998cited by this paper
• Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity.

  1998cited by this paper
• Interaction of the Bovine Papillomavirus E6 Protein with the Clathrin Adaptor Complex AP-1

  1998cited by this paper
• Inhibition of Bak-induced apoptosis by HPV-18 E6

  1998cited by this paper
• HMG box proteins bind to four‐way DNA junctions in their open conformation

  1998cited by this paper
• HPV16 E6 oncoprotein stimulates the transforming growth factor-beta 1 promoter in fibroblasts through a specific GC-rich sequence.

  1997cited by this paper
• Molecular analysis of the interaction between HPV type 16 E6 and human E6‐associated protein

  1997cited by this paper
• Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein.

  1997cited by this paper
• The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton.

  1997cited by this paper
• Domain organization and DNA-induced conformational changes of an archaeal family B DNA polymerase.

  1996cited by this paper
• NMRPipe: A multidimensional spectral processing system based on UNIX pipes

  1995cited by this paper
• Measuring protein self-association using pulsed-field-gradient NMR spectroscopy: Application to myosin light chain 2

  1995cited by this paper
• Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein.

  1995cited by this paper
• The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest

  1994cited by this paper
• Mutational analysis of HPV-18 E6 identifies domains required for p53 degradation in vitro, abolition of p53 transactivation in vivo and immortalisation of primary BMK cells.

  1994cited by this paper
• Activation of the c-fos gene by the HPV16 oncoproteins depends upon the cAMP-response element at -60.

  1994cited by this paper
• The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53.

  1993cited by this paper
• Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions

  1992cited by this paper
• Human papillomaviruses in the pathogenesis of anogenital cancer.

  1991cited by this paper
• The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture

  1991cited by this paper
• Human papillomavirus type 16 E6 proteins with glycine substitution for cysteine in the metal-binding motif.

  1991cited by this paper
• The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53.

  1990cited by this paper
• Papillomavirus polypeptides E6 and E7 are zinc-binding proteins

  1989cited by this paper
• E6 protein of human papillomavirus type 18 binds zinc.

  1989cited by this paper
• The structure of the Holliday junction, and its resolution.

  1988cited by this paper
• Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome. Phylogeny of papillomaviruses and repeated structure of the E6 and E7 gene products.

  1987cited by this paper
• Identification of the HPV‐16 E6 protein from transformed mouse cells and human cervical carcinoma cell lines.

  1987cited by this paper

• Machine learning-based insights on the structural variations found in the C-terminal domains of differing human papillomavirus E6 and E7 protein models across geography, variants, and risk type

  2026cites this paper
• Reversibly Reactive Affinity Selection-Mass Spectrometry Enables Identification of Covalent Peptide Binders.

  2024cites this paper
• The polymorphism analysis and therapy vaccine target epitopes screening of HPV-35 E6 E7 among the threaten α-9 HPV in Sichuan area

  2024cites this paper
• Why HPV16? Why, now, HPV42? How the discovery of HPV42 in rare cancers provides an opportunity to challenge our understanding about the transition between health and disease for common members of the healthy microbiota

  2024cites this paper
• Too many cooks in the kitchen: HPV driven carcinogenesis – The result of collaboration or competition?

  2024cites this paper
• Discovery of reactive peptide inhibitors of human papillomavirus oncoprotein E6

  2023cites this paper
• The polymorphism analysis and epitope predicted of Alphapapillomavirus 9 E6 in Sichuan, China

  2022cites this paper
• The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis

  2021cites this paper
• Human papillomavirus 68 prevalence and genetic variability based on E6/E7 genes in Sichuan.

  2021cites this paper
• Human papillomavirus type 68 prevalence and genetic variability based on E6/E7 genes in Sichuan

  2021cites this paper
• Molecular modeling simulation studies reveal new potential inhibitors against HPV E6 protein

  2019cites this paper
• The role of post translational modification in regulating Human Papillomavirus (HPV) E6 functions

  2018cites this paper
• Novel structural approaches concerning HPV proteins: Insight into targeted therapies for cervical cancer (Review).

  2018cites this paper
• Structural Insights in Multifunctional Papillomavirus Oncoproteins

  2018cites this paper
• MicroRNA and gynecologic cancers

  2016cites this paper
• A prime/boost strategy using DNA/fowlpox recombinants expressing the genetically attenuated E6 protein as a putative vaccine against HPV-16-associated cancers

  2015cites this paper
• Disordered interactome of human papillomavirus.

  2014cites this paper
• Identi fi cation and Characterization of Small Molecule Human Papillomavirus E 6 Inhibitors

  2014cites this paper
• Prediction of intrinsic disorder in proteins using MFDp2.

  2014cites this paper
• An in silico appraisal of azoic and disulphide derivatives for anticancer activity against HPV E6 oncoprotein to medicate cervical cancer.

  2014cites this paper
• Protein Structure Prediction

  2014cites this paper
• Probing the effect of conformational changes in protein complexes by vibrational spectroscopy : bioenergetics and allostery

  2014cites this paper
• Identification and Characterization of Small Molecule Human Papillomavirus E6 Inhibitors

  2014cites this paper
• Structural disorder in viral proteins.

  2014cites this paper
• The Active Form of E6-associated protein (E6AP)/UBE3A Ubiquitin Ligase Is an Oligomer*

  2013cites this paper
• Papillomavirus E6 oncoproteins.

  2013cites this paper
• The Active Form of E6AP/UBE3A Ubiquitin Ligase Is An Oligomer

  2013cites this paper
• The Active Form of E 6 AP / UBE 3 A Ubiquitin Ligase is an Oligomer

  2013cites this paper
• Regulation of Human Papillomavirus Type 16 Late L1 mRNA Splicing

  2013influential citation
• Human papilloma virus 16 e6 protein as a target for curcuminoids, curcumin conjugates and congeners for chemoprevention of oral and cervical cancers

  2013cites this paper
• Solution structure analysis of the HPV16 E6 oncoprotein reveals a self-association mechanism required for E6-mediated degradation of p53.

  2012cites this paper
• Análisis estructural y conformacional de E6*I, un producto de procesamiento alternativo derivado de la oncoproteína E6 de HPV16

  2012cites this paper
• Identification and Characterization of Small Molecule Antagonists of the Human Papillomavirus Oncoproteins

  2012influential citation
• E6*, the 50 amino acid product of the most abundant spliced transcript of the e6 oncoprotein in high-risk human papillomavirus, is a promiscuous folder and binder.

  2011cites this paper
• Detecting genomic regions associated with a disease using variability functions and Adjusted Rand Index

  2011cites this paper
• Strategies for bacterial expression of protein-peptide complexes: application to solubilization of papillomavirus E6.

  2011cites this paper
• Evolution of human papillomavirus carcinogenicity.

  2010cites this paper
• Prevalence of intrinsic disorder in the hepatitis C virus ARFP/Core+1/S protein

  2010cites this paper
• E6 proteins from diverse papillomaviruses self-associate both in vitro and in vivo.

  2010cites this paper
• A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells

  2009cites this paper
• Identification of Unusual E6 and E7 Proteins within Avian Papillomaviruses: Cellular Localization, Biophysical Characterization, and Phylogenetic Analysis

  2009cites this paper
• Human papillomavirus type 16 E2 and E6 are RNA-binding proteins and inhibit in vitro splicing of pre-mRNAs with suboptimal splice sites.

  2009cites this paper
• Determinants of stability for the E6 protein of papillomavirus type 16.

  2009cites this paper
• Defining the minimal interacting regions of the tight junction protein MAGI-1 and HPV16 E6 oncoprotein for solution structure studies.

  2008cites this paper
• SPR identification of mild elution conditions for affinity purification of E6 oncoprotein, using a multivariate experimental design

  2008cites this paper
• Structure and function of the papillomavirus E6 protein and its interacting proteins.

  2008cites this paper
• Formation of well-defined soluble aggregates upon fusion to MBP is a generic property of E6 proteins from various human papillomavirus species.

  2007cites this paper
• NMR in the SPINE Structural Proteomics project.

  2006cites this paper
• Protein intrinsic disorder and human papillomaviruses: increased amount of disorder in E6 and E7 oncoproteins from high risk HPVs.

  2006cites this paper
• Identification of inhibitors to papillomavirus type 16 E6 protein based on three-dimensional structures of interacting proteins.

  2006cites this paper
• Structural and functional analysis of E6 oncoprotein: insights in the molecular pathways of human papillomavirus-mediated pathogenesis.

  2006cites this paper
• Capturing protein-protein complexes at equilibrium: the holdup comparative chromatographic retention assay.

  2006cites this paper
• Kinetic analysis of the interactions of human papillomavirus E6 oncoproteins with the ubiquitin ligase E6AP using surface plasmon resonance.

  2005cites this paper
• 1H and 15N resonance assignment, secondary structure and dynamic behaviour of the C-terminal domain of human papillomavirus oncoprotein E6

  2005cites this paper
• Regulation of apoptosis by the papillomavirus E6 oncogene.

  2005cites this paper